Comparison between Aristo Bio-Tech IPO and DHARNI Capital IPO.
Aristo Bio-Tech IPO is a SME Fixed Price IPO proposed to list at NSE SME while DHARNI Capital IPO is a SME Fixed Price proposed to list at BSE SME.
| Aristo Bio-Tech IPO | DHARNI Capital IPO | |
|---|---|---|
| Logo |  |  |
| Issue Category | SME | SME |
| Issue Type | IPO | IPO |
| Process Type | Fixed Price | Fixed Price |
| Listing At | NSE SME | BSE SME |
| Lead Managers | Beeline Capital Advisors Pvt.Ltd. | Srujan Alpha Capital Advisors LLP |
| Registrar | MUFG Intime India Pvt.Ltd. | Cameo Corporate Services Ltd. |
| Market Maker | Sunflower Broking Pvt.Ltd. | Sunflower Broking Pvt.Ltd. |
| DRHP | DRHP  | DRHP |
| RHP | RHP | RHP |
| Final Prospectus | Final Prospectus | Final Prospectus |
| Anchor Investor | ||
| IPO Allotment URL | IPO Allotment URL | IPO Allotment URL |
The total issue size of Aristo Bio-Tech IPO is up to ₹12.40 Cr whereas the issue size of the DHARNI Capital IPO is up to ₹10.20 Cr. The final issue price of Aristo Bio-Tech IPO is ₹72.00 per share and of DHARNI Capital IPO is ₹20.00 per share.
| Aristo Bio-Tech IPO | DHARNI Capital IPO | |
|---|---|---|
| Face Value | ₹10 per share | ₹1 per share |
| Issue Price (Lower) | ||
| Issue Price (Upper) | ||
| Issue Price (Final) | ₹72.00 per share | ₹20.00 per share |
| Discount (Retail) | ₹0.00 per share | ₹0.00 per share |
| Discount (Employee) | ||
| Market Lot Size | 1600 shares | 6000 shares |
| Fresh Issue Size | 17,21,600 shares | 51,00,000 shares |
| Fresh Issue Size (Amount) | up to ₹12.40 Cr | up to ₹10.20 Cr |
| OFS Issue Size | 0 shares | 0 shares |
| OFS Issue Size (Amount) | up to ₹0.00 Cr | up to ₹0.00 Cr |
| Issue Size Total | 17,21,600 shares | 51,00,000 shares |
| Issue Size Total (Amount) | up to ₹12.40 Cr | up to ₹10.20 Cr |
Aristo Bio-Tech IPO opens on Jan 16, 2023, while DHARNI Capital IPO opens on Jan 18, 2023. The closing date of Aristo Bio-Tech IPO and DHARNI Capital IPO is Jan 19, 2023, and Jan 20, 2023, respectively.
| Aristo Bio-Tech IPO | DHARNI Capital IPO | |
|---|---|---|
| Anchor Bid Date | ||
| Issue Open | Jan 16, 2023 | Jan 18, 2023 |
| Issue Close | Jan 19, 2023 | Jan 20, 2023 |
| Basis Of Allotment (Tentative) | Jan 24, 2023 | Jan 25, 2023 |
| Initiation of Refunds (Tentative) | Jan 25, 2023 | Jan 27, 2023 |
| Credit of Share (Tentative) | Jan 27, 2023 | Jan 30, 2023 |
| Listing date (Tentative) | Jan 30, 2023 | Jan 31, 2023 |
| Anchor Lockin End date 1 | ||
| Anchor Lockin End date 2 |
Aristo Bio-Tech IPO P/E ratio is 9.46, as compared to DHARNI Capital IPO P/E ratio of 34.48.
| Aristo Bio-Tech IPO | DHARNI Capital IPO | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Financials | Company Financials (Restated)
| Company Financials (Restated Standalone)
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Promoter Shareholding (Pre-Issue) | 100.00 | 100.00 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Promoter Shareholding (Post-Issue) | 73.37 | 73.64 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| P/E Ratio | 9.46 | 34.48 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Market Cap | ₹49.02 Cr. | ₹40.74 Cr. | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| ROE | 29.26 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| ROCE | 35.64 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Debt/Equity | 5.10 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| EPS | ₹2.93 | ₹5.46 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| RoNW | 10 | 42.6 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
In the Aristo Bio-Tech IPO Retail Individual Investors (RII) are offered 8,60,800 shares while in DHARNI Capital IPO retail investors are offered 8,60,800 shares. Qualified Institutional Buyers (QIB) are offered in Aristo Bio-Tech IPO and in DHARNI Capital IPO.
| Aristo Bio-Tech IPO | DHARNI Capital IPO | |
|---|---|---|
| Anchor Investor Reservation | ||
| Market Maker Reservation | 91,200 shares | 2,70,000 shares |
| QIB | ||
| NII | 8,60,800 shares | 25,50,000 shares |
| RII | 8,60,800 shares | 25,50,000 shares |
| Employee | ||
| Others | ||
| Total | 17,21,600 shares | 51,00,000 shares |
Aristo Bio-Tech IPO subscribed 217.72x in total, whereas DHARNI Capital IPO subscribed 6.57x.
| Aristo Bio-Tech IPO | DHARNI Capital IPO | |
|---|---|---|
| QIB (times) | ||
| NII (times) | 285.84x | 6.32x |
| Big NII (times) | ||
| Small NII (times) | ||
| RII (times) | 149.59x | 6.83x |
| Employee (times) | ||
| Other (times) | ||
| Total (times) | 217.72x | 6.57x |
